Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2026-02-26 @ 12:21 AM
Study NCT ID:
NCT07161193
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-09-08
First Post:
2025-08-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases
Sponsor:
Hebei Senlang Biotechnology Inc., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
L2025021-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None